Showing results (1811-1820 of 2,394) with videos related to
Sort By:
Pageof 240
The AAPS Journal|July 24, 2010
Application of quantitative pharmacology in development of therapeutic monoclonal antibodiesMohammad Tabrizi, Cherryl Funelas, Hamza SuriaThe AAPS Journal|September 18, 2010
Fishing for the hidden peptidome in health and disease (drug abuse)Lloyd D Fricker, Jonathan V SweedlerThe AAPS Journal|September 22, 2010
Modeling disease progression in acute stroke using clinical assessment scalesKristin E Karlsson, Justin J Wilkins, Fredrik Jonsson, et al.The AAPS Journal|June 17, 2010
Peptidomics of the prolyl peptidasesAnna Mari Lone, Whitney M Nolte, Arthur D Tinoco, et al.The AAPS Journal|December 25, 2010
Dopamine D2 occupancy as a biomarker for antipsychotics: quantifying the relationship with efficacy and extrapyramidal symptomsRik de Greef, Alan Maloney, Per Olsson-Gisleskog, et al.The AAPS Journal|February 10, 2009
Model-based decision making in early clinical development: minimizing the impact of a blood pressure adverse eventMark Stroh, Carol Addy, Yunhui Wu, et al.The AAPS Journal|March 31, 2011
Translational biomarkers: from preclinical to clinical a report of 2009 AAPS/ACCP Biomarker WorkshopJane P F Bai, Robert Bell, ShaAvhree Buckman, et al.The AAPS Journal|May 17, 2019
In Vitro Metabolism and Hepatic Intrinsic Clearance of the Synthetic Cannabinoid Receptor Agonist JWH-122 and Its Four ω-Halogenated AnaloguesAnders Bork Davidsen, Marie Mardal, Kristian LinnetThe AAPS Journal|May 8, 2019
Fc-Fusion Drugs Have FcγR/C1q Binding and Signaling Properties That May Affect Their ImmunogenicityH A Daniel Lagassé, Hartmut Hengel, Basil Golding, et al.The AAPS Journal|April 10, 2019
CAR T Cell Immunotherapy in Human and Veterinary Oncology: Changing the Odds Against Hematological MalignanciesJonathan P Mochel, Stephen C Ekker, Chad M Johannes, et al.Pageof 240